Pharma Reviews: Agilent continues to focus on strategic M&A, R&D investment to expand product portfolio

Although Indian companies are known for producing generic pharma drugs, many companies are now moving into the global biopharma market to ...
Read more: Agilent continues to focus on strategic M&A, R&D investment to expand product portfolio